Binding Modes of Thalidomide Derivatives in Cereblon-Neosubstrate Complexes Revealed by Molecular Dynamics and Free Energy Calculations. [PDF]
ACS OmegaMartín V +4 more
europepmc +1 more source
Low- to moderate-dose thalidomide combination rescue after luspatercept failure in transfusion-dependent β-thalassemia: a real-world cohort study. [PDF]
Ann HematolNanthachak S +5 more
europepmc +1 more source
THE METABOLISM OF THALIDOMIDE: THE SPONTANEOUS HYDROLYSIS OF THALIDOMIDE IN SOLUTION [PDF]
British Journal of Pharmacology and Chemotherapy, 1965 H, Schumacher, R L, Smith, R T, Williams
openaire +2 more sources
Genetically defined systemic autoinflammatory diseases in pediatric patients with Behçet's disease. [PDF]
Front ImmunolZheng S +13 more
europepmc +1 more source
, 2002 A la fin des années 50, une société pharmaceutique allemande, la Chemie Grünenthal mit au point un tranquillisant, la thalidomide. Ce sédatif à l'origine inoffensif, fur lancé sur le marché dans une cinquantaine de pays.
JANICKI, Jérôme Jean +1 more
core
Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations. [PDF]
Clin Pharmacol TherBurckart GJ +8 more
europepmc +1 more source
Targeting fibrosis in the treatment of lower urinary tract dysfunction. [PDF]
J PatholLimkar AR +6 more
europepmc +1 more source
Refractory Adult-Onset Localized Cutaneous Langerhans Cell Histiocytosis Successfully Treated with Surgical Intervention: Case Report. [PDF]
Clin Cosmet Investig DermatolTan Y +7 more
europepmc +1 more source